Last $50.62 USD
Change Today -0.50 / -0.98%
Volume 8.2M
BMY On Other Exchanges
Symbol
Exchange
New York
Mexico
Sao Paulo
Frankfurt
As of 8:04 PM 07/31/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael Grobstein

Director, Member of Audit Committee and Member of Compensation & Management Development Committee, Bristol-Myers Squibb Company
AgeTotal Calculated CompensationThis person is connected to 81 board members in 4 different organizations across 5 different industries.

See Board Relationships
71$310,000

Background*

Mr. Michael Grobstein, also known as Mike, served as a Partner of Ernst & Young LLP since 1975. Mr. Grobstein worked at Ernst & Young LLP from 1964 to 1998 and served as its Vice Chairman of International Operations from 1993 to 1998, Vice Chairman of Planning, Marketing and Industry Services from 1987 to 1993 and Vice Chairman of Accounting and Auditing Services from 1984 to 1987, where Mr. Grobstein was responsible for the global strategic planning and was also responsible ...

Read Full Background

Corporate Headquarters*

345 Park Avenue
New York, New York 10154

United States

Phone: 212-546-4000
Fax: 212-546-4020

Board Members Memberships*

Trustee
1999-N/A
Former Director, Chairman of Audit Committee and Member of Corporate Governance Committee
2001-N/A
Former Outside Director, Member of Audit Committee and Member of Compensation & Nominating Committee
2001-Present
Director
2007-Present
Director, Member of Audit Committee and Member of Compensation & Management Development Committee
2014-Present
Director

Education*

BS
University of Illinois-Urbana-Champaign

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$150,000
Total Calculated Compensation$310,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BMY:US $50.62 USD -0.50

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.5M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BRISTOL-MYERS SQUIBB CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.